(Q37703184)

22 August 2017

1 reference

title

Sodium-glucose co-transport inhibitors: progress and therapeutic potential in type 2 diabetes mellitus (English)

1 reference

22 August 2017

0 references

0 references

0 references

Joshua J Neumiller

1

1 reference

22 August 2017

John R White

series ordinal

2

1 reference

22 August 2017

R Keith Campbell

series ordinal

3

1 reference

22 August 2017

language of work or name

1 reference

1 March 2010

1 reference

22 August 2017

1 reference

22 August 2017

70

1 reference

22 August 2017

4

1 reference

22 August 2017

377-385

1 reference

https://scigraph.springernature.com/pub.10.2165/11318680-000000000-00000

22 August 2017

0 references

cites work

Glucose transporter and Na+/glucose cotransporter as molecular targets of anti-diabetic drugs

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11318680-000000000-00000

Inhibition of renal glucose reabsorption: a novel strategy for achieving glucose control in type 2 diabetes mellitus

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11318680-000000000-00000

Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11318680-000000000-00000

Dapagliflozin, a novel SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects

21 January 2018

1 reference

12 December 2020

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

1 reference

12 December 2020

Sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes

1 reference

12 December 2020

Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine

1 reference

12 December 2020

The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose

1 reference

12 December 2020

The high affinity Na+/glucose cotransporter. Re-evaluation of function and distribution of expression.

1 reference

12 December 2020

THE ACTION OF PHLORIZIN ON THE EXCRETION OF GLUCOSE, XYLOSE, SUCROSE, CREATININE AND UREA BY MAN.

1 reference

12 December 2020

Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models

1 reference

12 December 2020

Renal gluconeogenesis: its importance in human glucose homeostasis

1 reference

12 December 2020

The sodium/glucose cotransport family SLC5

1 reference

12 December 2020

Discontinued drugs in 2008: endocrine and metabolic

1 reference

12 December 2020

Renal glucose threshold variations with age

1 reference

12 December 2020

Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999-2004.

1 reference

12 December 2020

Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus

1 reference

12 December 2020

T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats

1 reference

12 December 2020

Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes

1 reference

12 December 2020

Dipeptidyl peptidase-4 as a new target of action for type 2 diabetes mellitus: a systematic review

1 reference

12 December 2020

Glucose control by the kidney: an emerging target in diabetes

1 reference

12 December 2020

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

12 December 2020

Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level

1 reference

12 December 2020

1 reference

12 December 2020

A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: applicability of a novel insulin-independent treatment

1 reference

12 December 2020

Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey

1 reference

12 December 2020

Active sugar transport in health and disease

1 reference

12 December 2020

Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats

1 reference

12 December 2020

Sodium-glucose co-transporter-2 inhibitors: an emerging new class of oral antidiabetic drug

1 reference

12 December 2020

Renal Na(+)-glucose cotransporters

1 reference

12 December 2020

The association of glycemia and cause-specific mortality in a diabetic population

1 reference

12 December 2020

Renal glucose production and utilization: new aspects in humans

1 reference

12 December 2020

Glycosylated dihydrochalcones as potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitors

1 reference

12 December 2020

Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications

1 reference

12 December 2020

Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

1 reference

12 December 2020

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

12 December 2020

Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes

1 reference

12 December 2020

10.2165/11318680-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

22 August 2017

0 references

1 reference